Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Marilyne Labrie

A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

scientific article published on 30 September 2021

A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer

scientific article published on 13 July 2015

A multi-encoder variational autoencoder controls multiple transformational features in single-cell image analysis

scientific article published on 23 March 2022

A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer

scientific article published on 26 April 2018

Abstract 448: Expression of Galectins in high grade serous ovarian cancer

Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options

scientific article published on 28 May 2019

An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer

scientific article published on 15 February 2022

Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake

scientific article published on 17 June 2015

Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter.

scientific article published on 30 May 2013

Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

scientific article published on 15 October 2019

Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.

scientific article

Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

scientific article published on October 2015

Epigenetic regulation of mmp-9 gene expression

scientific article

Expression and functions of galectin-7 in ovarian cancer.

scientific article

Expression of galectin-7 is induced in breast cancer cells by mutant p53.

scientific article

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

scientific article published on 20 February 2018

Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets

scientific article published on 27 February 2016

Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers

scientific article published on 10 May 2022

Intracellular galectins in cancer cells: potential new targets for therapy (Review).

scientific article published on 21 January 2014

Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies

scientific article published on 19 October 2021

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness

scientific article published on 27 November 2018

Proteomics advances for precision therapy in ovarian cancer

scientific article published on 13 September 2019

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

scientific article published on 01 June 2019

Systems approach to rational combination therapy: PARP inhibitors

scientific article published on 07 May 2020

The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cells

scientific article

Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers

scientific article published on 16 October 2017

Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance

scientific article published on 01 January 2019

Paulina is supported by:

About Paulina

Help